National Academies Press: OpenBook

Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary (2010)

Chapter: Appendix B: Workshop Speakers and Moderators

« Previous: Appendix A: Workshop Agenda
Suggested Citation:"Appendix B: Workshop Speakers and Moderators." Institute of Medicine. 2010. Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12779.
×

Appendix B
Workshop Speakers and Moderators

Rafael G. Amado, Oncology Medicine Development Center, GlaxoSmithKline

Fred Appelbaum, Clinical Research Division, Fred Hutchinson Cancer Research Center

Peter B. Bach, Memorial Sloan-Kettering Cancer Center

Amy Bassano, Center for Medicare Management, Centers for Medicare & Medicaid Services

Amy Bonoff, National Breast Cancer Coalition

Wylie Burke, Department of Medical History & Ethics, University of Washington

Ralph Coates, Coordinating Center for Health Promotion, Centers for Disease Control and Prevention

Robert Erwin, Marti Nelson Cancer Foundation

Andrea Ferreira-Gonzalez, Department of Pathology, Virginia Commonwealth University

Stephen Friend, Sage Bionetworks

Alberto Gutierrez, Office of In Vitro Diagnostic Devices, Food and Drug Administration

Steven Gutman, College of Medicine, University of Central Florida

Daniel F. Hayes, University of Michigan Comprehensive Cancer Center

Roy S. Herbst, Thoracic/Head & Neck Medical Oncology, M.D. Anderson Cancer Center

Suggested Citation:"Appendix B: Workshop Speakers and Moderators." Institute of Medicine. 2010. Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12779.
×

Gail Javitt, Genetics and Public Policy Center, Johns Hopkins University

Bruce E. Johnson, Dana-Farber Cancer Institute

Debra G. B. Leonard, Weill Cornell Medical College, New York-Presbyterian Hospital

Robert Mass, Genentech, Inc.

Penelope Meyers, Division of Laboratory Services, Centers for Medicare & Medicaid Services

David R. Parkinson, Nodality, Inc.

Bruce Quinn, Foley Hoag, LLP

Mark J. Ratain, University of Chicago Hospitals

Jeffrey C. Roche, Coverage and Analysis Group, Centers for Medicare & Medicaid Services

Richard Schilsky, University of Chicago, Cancer and Leukemia Group B

Steven Shak, Genomic Health, Inc.

Donald Small, Sidney Kimmel Comprehensive Cancer Center

Risa Stack, Kleiner Perkins Caulfield and Byers

Suggested Citation:"Appendix B: Workshop Speakers and Moderators." Institute of Medicine. 2010. Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12779.
×
Page 81
Suggested Citation:"Appendix B: Workshop Speakers and Moderators." Institute of Medicine. 2010. Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12779.
×
Page 82
Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary Get This Book
×
 Policy Issues in the Development of Personalized Medicine in Oncology: Workshop Summary
Buy Paperback | $29.00 Buy Ebook | $23.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

One of the challenges in treating cancer is the disease's complexity and variation among patients. Cancer manifests differently in each patient, so treatments that are effective in one patient may not be effective in another. As cancer care becomes more personalized, subpopulations of individuals will be given preventive or therapeutic interventions based on their susceptibility to a particular disease or their predicted response to a specific treatment. However, before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of technological, regulatory, and reimbursement issues.

To explore these policy challenges, the National Cancer Policy Forum held the workshop Policy Issues in the Development of Personalized Medicine in Oncology in June 2009. Experts provided presentations on the current state of personalized medicine technology, as well as issues in the validation of, regulation of, and reimbursement for the predictive tests that underpin personalized medicine. Participants discussed the obstacles and possible solutions to further developing and using personalized medicine technologies. This document summarizes the workshop.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!